A new series of 5-(p-substituted benzamido/phenylacetamido)-2-(p-tert-butylphenyl)benzoxazole derivatives were synthesized and evaluated for their antibacterial, antifungal, and antimycobacterial activities against antibiotic-resistant and -sensitive Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, and Mycobacterium tuberculosis as well as against Candida albicans and Candida krusei. The compounds possessed broad-spectrum activity against all of the tested Gram-positive and Gram-negative bacteria and yeasts, their minimum inhibitory concentrations (MICs) ranging between 16 -128 μg/ml. One compound exhibited signifi cant antibacterial activity (16 μg/ml) against an antibioticresistant Enterococcus faecalis isolate, having twice the potency of the compared standard drugs vancomycin and gentamycin sulfate. The compounds also showed moderate antitubercular activity with MIC values between 8 -128 μg/ml against Mycobacterium tuberculosis and its clinical isolate.
Introduction
Tuberculosis, gonorrhea, malaria, and childhood ear infections are just a few diseases that have become hard to treat with antibiotic drugs. Especially tuberculosis still remains a major public health problem, and it is estimated that new infections of humans by Mycobacterium tuberculosis are greater than 8 million annually and more than 3 million people die from this disease each year (Kochi et al., 2002) . The struggle against bacterial infections has resulted in the development of a wide variety of antibiotics. After years of misuse of antibiotics bacteria have become antibiotic-resistant, resulting in a potential global health crisis. Also many hospital-acquired infections are resistant to the most powerful antibiotics available, like methicillin and vancomycin. These drugs are reserved to treat only the most intractable infections to slow the development of resistance to them (Fridgin and Gaynes, 1999) . So, there is an urgent need for new classes of antitubercular and antimicrobial agents.
Benzoxazoles are structural isosters of natural nucleotides which interact easily with biopolymers, and they constitute an important class of heterocyclic compounds with antitubercular, antimicrobial, and antibiotic activities (Prudhomme et al., 1986; Haansuu et al., 2001; Kochi et al., 2002; Temiz-Arpaci et al., 2002a, b; Sarma et al., 2003; Vinsova et al., 2005 Vinsova et al., , 2006 . The benzoxazole derivative calcimycin is a carboxylic polyether antibiotic from a strain of Streptomyces chartreusis (NRRL 3882) . It is highly active against Grampositive bacteria including some Bacillus and Micrococcus strains (Prudhomme et al., 1986) .
In recent years, we have described the synthesis of various derivatives of some 2,5-disubstituted benzoxazoles and their in vitro antimicrobial activity against some Gram-positive and Gram-negative bacteria and the fungus Candida albicans (Temiz-Arpaci et al., 2002a , b, 2008 Alper-Hayta et al., 2008; Arisoy et al., 2012) . In the present study, we aimed to develop new effective antitubercular and antimicrobial agents possessing benzoxazole nuclei in their structure. Here, we describe the synthesis of a series of 5-(p-substituted benzamido/phenylacetamido)-2-(p-tert-butylphenyl)benzoxazole derivatives as a new class of synthetic antitubercular and antimicrobial agents along with results of testing their in vitro antitubercular and antimicrobial activities against some Gram-negative and Gram-positive bacteria as well as Mycobacterium tuberculosis, Candida albicans, and Candida krusei. We put a p-tert-butylphenyl moiety in position 2 of the benz oxazole ring. We considered that this lipophilic group might improve the antitubercular activity, because it permits an easier penetration of the molecule through the lipophilic mycobacterial cell walls.
Material and Methods

Chemicals and analytical methods
The chemicals and solvents were purchased from Sigma-Aldrich (Munich, Germany) and Fisher Scientifi c (Pittsburgh, PA, USA); they were used without purifi cation. Silica gel HF 254 chromatoplates (0.3 mm) were used for thin-layer chromatography, and the mobile phase was chloroform/methanol (10:0.5, v/v). Melting points were recorded on a Stuart Scientifi c SMP 1 instrument (Bibby Scientifi c Limited, Stone, Staffordshire, UK) and are uncorrected. NMR spectra were recorded on a Varian Mercury 400 MHz NMR spectrometer (Palo Alto, CA, USA) in CDCl 3 or dimethylsulfoxide (DMSO-d 6 ); tetramethylsilane (TMS) was used as an internal standard. The mass spectra were recorded on a Waters ZQ Micromass LC-MS spectrometer (Milford, MA, USA) using the ESI(+) method. 
Materials for microbiology
General procedure for the preparation of the 5-(p-substituted benzamido/phenylacetamido)-2-(p-tert-butylphenyl)benzoxazoles 6 -20
Firstly, 5-amino-2-(p-tert-butylphenyl)benzoxazole (3) was synthesized by heating 0.02 mol 2,4-diaminophenol · 2 HCl (1) with 0.02 mol ptert-butylbenzoic acid (2) in 25 g polyphosphoric acid (PPA) and stirring the resulting mixture for 3 -4 h. At the end of the reaction period, the residue was poured into an ice/water mixture, and the solution was neutralized with 10% NaOH. The resulting precipitate was fi ltered, washed with distilled water, dissolved in boiling ethanol with 0.2 g charcoal, and fi ltered. Distilled water was slowly added to the fi ltrate in order to stimulate crystallization. The crude compound 3 was obtained by fi ltering and drying the crystalline material . Then, appropriate carboxylic acids 4 (0.5 mmol) and thionyl chloride (1.5 ml) were refl uxed in benzene (5 ml) at 80 °C for 3 h. Excess thionyl chloride was removed in vacuo. The appropriate carboxylic acyl chlorides 5 were dissolved in diethyl ether (10 ml), and this solution was added, during 1 h, to a stirred, ice-cold mixture of 5-amino-2-(p-tertbutylphenyl)benzoxazole (3) (0.5 mmol), sodium bicarbonate (0.5 mmol), diethyl ether (10 ml), and water (10 ml). The mixture was kept stirred overnight at room temperature and then fi ltered. The precipitate was washed with water, 2 M HCl, and water, respectively, and fi nally with diethyl ether to give compounds 6 -20. The products were recrystallized from ethanol/water as needles which were dried in vacuo. Physical and spectral data of compounds 6 -20 are reported in Table I .
Microbiological assays
For microbiological assays, the standard antibio tics were dissolved in the appropriate solvents recommended by Clinical and Laboratory Standards Institute guidelines (CLSI, 2006 (CLSI, , 2008 . Stock solutions of the test compounds were prepared in DMSO.
Bacterial susceptibility testing was performed according to the guidelines of CLSI (M100-S18; CLSI, 2008). MHB was added to each well of the microplates. The bacterial suspensions used for inoculation were prepared at 10 6 CFU/ml by diluting fresh cultures at McFarland 0.5 density. Suspensions of the bacteria at 10 6 CFU/ml were inoculated to the two-fold diluted solution of the compounds. A 10-μl bacterium inoculum was added to each well of the microplates. There were 10 5 CFU/ml bacteria in the wells after inoculations. Microplates were incubated at 37 °C overnight. Fungal susceptibility testing was performed according to the guidelines of CLSI (M27-A3; CLSI, 2006) . RPMI-1640 medium with L-glutamine buffered to pH 7 with MOPS was added to each well of the microplates. The colonies were suspended in sterile saline, and the resulting suspension was adjusted to McFarland 0.5 density. A working suspension was prepared by appropriate dilution of the stock suspension. A 10-μl inoculum was added to each well of the microplates resulting in 10 3 CFU/ml yeasts in the wells. Microplates were incubated at 35 °C for 24 -48 h.
After incubation, the lowest concentration of the compounds that completely inhibited macroscopic growth was determined and reported as minimum inhibitory concentration (MIC). All solvents and diluents, pure microorganisms, and pure media were used in control wells. All experiments were done in three parallel series. The data on the antimicrobial activity of the compounds and the control drugs as MIC values (μg/ml) are given in Table II .
Results and Discussion
The synthetic pathway for preparation of the target compounds is shown in Scheme 1. First, 5-amino-2-(p-tert-butylphenyl)benzoxazole (3) Fig. 1 . Synthesis of the target compounds 6 -20.
was obtained by heating p-tert-butylbenzoic acid (2) with 2,4-diaminophenol (1) in polyphosphoric acid (PPA) . Compounds 6 -20 were obtained by reaction of 3 with p-substituted benzoic or phenylacetic acyl chlorides 5 that were synthesized by treating appropriate benzoic or phenylacetic acids with thionyl chloride (Temiz-Arpaci et al., 2002a) . The structures of the 2,5-disubstituted benzoxazoles 6 -20 synthesized were elucidated by IR, mass, and 1 H NMR spectroscopy. Physical and spectral data of the synthesized benzoxazole derivatives are given in Table I .
The IR spectra of the fi nal compounds showed the characteristic C=O stretching band in the 1636 -1670 cm -1 region. Besides, C=N stretching bands were observed in the 1488 -1544 cm -1 region. In the 1 H NMR spectra of compounds 7 -10, 12 -14 the signal of the NH proton was invisible, and in the other compounds the signal of the NH proton was observed at δ H 10.77 -8.95 ppm as a singlet band. Benzylic CH 2 protons were observed at δ H 3.89 -3.60 ppm as a singlet band for compounds 7, 12, 15, and 18 -20. Aromatic methyl protons appeared at δ H 3.00 and 2.26 ppm for compounds 13 and 15, respectively, as a singlet band. Aromatic protons were observed in the expected regions. Mass spectra of the compounds showed [M + + H] peaks, since the electrospray ionization method was employed.
In vitro antimicrobial and antitubercular activity results of the compounds tested are given in Table II . The synthesized compounds were found to possess MIC values between 32 -128 μg/ml for Gram-negative bacteria. Compounds 17, 19, and 20 were the most potent derivatives (MIC 32 μg/ ml) against the drug-resistant Escherichia coli isolate, having twice the potency of the standard drug ofl oxacin. Thus, the compounds having a pcyanophenylacetamido, p-nitrophenylacetamido or p-bromophenylacetamido group in position 5 of the benzoxazole ring had higher activity against the Escherichia coli isolate than the other tested compounds. However, all compounds showed lower antibacterial activity against the antibioticsensitive Escherichia coli strain (MIC 32 -64 μg/ ml) than did the control drugs. All synthesized compounds were found to have a more potent antibacterial activity (MIC 64 -128 μg/ml) against the drug-resistant Klebsiella pneumoniae isolate than did gentamycin sulfate (MIC 256 μg/ml).
As is evident from Table II , the synthesized compounds showed activity with MIC values of 16 -128 μg/ml against the Gram-positive bacteria, such as Staphylococcus aureus and Enterococcus faecalis and their drug-resistant isolates. Compound 20 was the most active one (MIC 16 μg/ ml) against the Enterococcus faecalis isolate, having twice the potency of the standard drugs vancomycin and gentamycin sulfate, and compound 19 showed the same activity as these standard drugs. These results indicate that the presence of the phenylacetamido moiety with a bromine atom or nitro group as the substituent at position 5 increases the potency against the drug-resistant Enterococcus faecalis isolate.
Moreover, all of the synthesized compounds exhibited weak antifungal activity against Candida albicans and Candida krusei with MIC values of 64 μg/ml and were thus less active than the tested reference drugs amphotericin B and fl uconazole. Compounds 6 -20 showed the same activity against Candida krusei as did the standard drug fl uconazole.
The synthesized compounds possessed in vitro activity against Mycobacterium tuberculosis and its clinical isolate. The MIC values were in the range of 8 -128 μg/ml. The most active compounds in the series -6, 7, and 15 -had MIC values of 8 μg/ml. It can be concluded that the compounds having a hydrogen atom or fl uorine atom or a methyl group as the substituent R of the benzamido/phenylacetamido moiety have increased potency against Mycobacterium tuberculosis. However, none of the synthesized compounds showed better antitubercular activity than did the standard drugs isoniazid and ethambutol.
These observations may serve as a starting point for the design of further antimicrobial and antitubercular drugs.
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